The risk of coronary heart disease remains low in Japan, although distributions of several coronary risk factors have become comparable with those in the United States. We prospectively compared coronary atherosclerosis burden, measured with coronary artery calcium (CAC) progression, between men in the 2 countries.
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Hisamatsu et al; CAC Progression Among US and Japanese Men C ompared with the United States and other developed countries, Japan has had a much lower rate of coronary heart disease (CHD) mortality, and this has largely been attributed to population-wide lower concentrations of serum total cholesterol.
1,2 The current comparison data still support this specific feature for CHD mortality in Japan. 3 Recently, however, the levels of several coronary risk factors have become comparable between the United States and Japan, particularly among men. 2 Serum total cholesterol levels in Japanese men have steadily increased and reached levels similar to those observed in US men. 2 In addition, Japanese men have a similar or higher prevalence of hypertension, diabetes mellitus, and cigarette smoking compared with US men. 2 Thus, some epidemiological studies in Japan have observed a trend of increasing CHD incidence among men because of less favorable coronary risk factor profiles, 4, 5 whereas overall CHD incidence in the United States appears to be declining in recent years. 3, 6, 7 Given these changing trends between the United States and Japan, it is of interest to investigate whether there is still a difference in the burden of coronary atherosclerosis between the 2 countries and, if there is, whether the difference between the 2 countries could be explained by the discrepancy in the distributions of traditional coronary risk factors.
Coronary artery calcium (CAC) is a well-established marker for coronary atherosclerosis 8 that, as assessed by the quantitative Agatston score, 9 correlates well with histological coronary plaque burden, 10, 11 and its presence and progression are strongly predictive of future coronary events. 12, 13 Comparing CAC scores is, therefore, likely to offer investigators the opportunity to gain insight into the overall burden of subclinical atherosclerosis. We previously found that CAC prevalence among Japanese men in Japan was substantially lower than among US white men, even after adjustment for traditional coronary risk factors. 14, 15 However, these studies were cross-sectional, and it remains unclear whether a difference in CAC progression exists between the 2 groups. In addition, no data are available on the comparison of CAC burden between black, Hispanic, and Chinese men in the US and Japanese men in Japan.
In the present study, using 2 prospective communitybased cohorts of US (the MESA [Multi-Ethnic Study of Atherosclerosis]) and Japanese men (the SESSA [Shia Epidemiological Study of Subclinical Atherosclerosis]), we aimed to compare the progression of CAC across multiethnic cohorts in the 2 countries and to determine whether race/ethnic differences persist after adjusting for traditional coronary risk factors.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing or expanding on the results after application to and approval by the MESA and SESSA Publications and Presentations Committees.
Study Population
The study population consisted of male participants who were free of clinical cardiovascular diseases from 2 cohort studies: MESA in the United States and SESSA in Japan. MESA was designed to examine the prevalence, incidence, and progression of subclinical atherosclerosis and their risk factors in a multiethnic cohort in the United States. 16 In brief, 6814 participants aged 45 to 84 years who identified themselves as white, black, Hispanic, or Chinese were recruited from 6 US communities (Forsyth County, NC; Northern Manhattan and the Bronx in New York City, NY; Baltimore City and Baltimore County, MD; St. Paul, MI; Chicago, IL; and Los Angeles County, CA) at baseline (2000-2002; response rate, 59.8%), and they were followed up to exam 6 (2016-2018) . SESSA is also an ongoing prospective study of subclinical atherosclerosis and its determinants in a community-based sample of Japanese residents. 17 In brief, Japanese men aged 40 to 79 years who lived in Kusatsu City, Shiga, Japan, were examined at baseline (2006) (2007) (2008) ; response rate, 46.0%) and followed up (2010) (2011) (2012) (2013) (2014) . Participants were identified on the basis of a random sample from the Kusatsu City Basic Residents Registration, which includes the name, age, and sex of all city residents. 15 In both cohorts, all participants provided written informed consent, and the study protocol was approved by each institution's institutional review board.
For the present study, we limited our analyses to male participants aged 45 to 74 years at baseline to ensure comparability because this age range is found in both cohorts. CAC data were used to estimate CAC progression from the baseline (2000-2002) to follow-up examinations (exam
CLINICAL PERSPECTIVE
The risk of coronary heart disease remains low in Japan, although distributions of several coronary risk factors have become comparable with those in the United States. We prospectively compared coronary atherosclerosis burden, measured with coronary artery calcium progression, between men in the 2 countries and found a higher coronary artery calcium incidence among US white men and greater increases in existing coronary artery calcium among all the US race/ethnic groups than among Japanese men in Japan. These differences also persisted despite adjustment for differences in coronary risk factors. These results suggest a higher coronary atherosclerosis burden and consequent risk for coronary heart disease among the US men as compared with Japanese men in Japan. Explanations responsible for these differences should be sought, which may inform clinical interpretation and our understanding of the pathophysiology of coronary atherosclerosis. 
CAC Measurement
A detailed description of the method of CAC measurement in MESA has been given elsewhere. 18 The protocol used to assess CAC in SESSA was the same as that in the preceding community-based multicenter study. 14, 19 In brief, for the 2 protocols, imaging software automatically identified a lesion of candidate CAC on the basis of predefined criteria. Then, a reader reviewed each candidate lesion to either accept or reject it and scored the accepted lesions according to the method of Agatston et al. 9 The criteria for automated identification were somewhat different between the 2 protocols. In MESA, 3 criteria needed to be met: computed tomographic (CT) attenuation of ≥130 Hounsfield Units, 4 contiguous pixels (1.15 mm 3 for 4-detector-row CT; 1.38 mm 3 for electron-beam CT), and location within an 8-mm radius of the coronary artery trajectory. 18 In SESSA, a CAC lesion was considered to be present with 3 contiguous pixels (1 mm 3 ) with attenuation of ≥130 Hounsfield Units. 15, 17 In MESA, participants were scanned twice at the baseline examination, and the average of Agatston scores obtained from the 2 images was used in the analysis, whereas participants were scanned once at the follow-up examinations. 20 In SESSA, participants were scanned once for each exam by either electron-beam CT or 16-detectorrow CT. 17 Based on a study of the duplicate images from 99 SESSA participants read at both imaging centers (ie, MESA and SESSA), we observed high intraclass correlation coefficients for correlation between MESA and SESSA, regardless of the type of CT (for electron-beam CT: intraclass correlation coefficient, 0.96 [95% CI, 0.93-0.98]; for multidetector-row CT: intraclass correlation coefficient, 0.95 [95% CI, 0.91-0.97]), and we found overall agreement across Agatston score levels from 0 to 3500, with no evidence of systematic difference. 21 The measurement of demographics and coronary risk factors is described in Methods in the Data Supplement.
Statistical Analysis
Distribution of demographics, behavioral and coronary risk factors, and medication uses among white, black, Hispanic, and Chinese men in the United States were compared with Japanese men in Japan using a t test or Wilcoxon rank-sum test for continuous variables and a χ 2 test or Fisher exact test for proportions.
Progression of CAC was defined in 2 ways, as previously described by Kronmal et al 22 :
(1) CAC incidence was defined as detectable CAC (CAC score, >0) at the follow-up examination in men free of detectable CAC (CAC score=0) at baseline examination and (2) annual change in CAC score in men who had detectable CAC (CAC score, >0) at baseline examination. The following multivariable models were fitted: model 1 was adjusted for age and education (high school or more versus less than high school) at baseline; model 2 was adjusted for model 1 covariates plus cigarette smoking status (never/former/current), pack-years of smoking, body mass index, systolic blood pressure, antihypertensive medications use (yes/no), total cholesterol, HDL (high-density lipoprotein) cholesterol, statin use (yes/no), and diabetes mellitus (yes/no) at baseline; and model 3 was adjusted for model 2 covariates plus changes in the behavioral and coronary risk factors and medication use between CT scans. CT scanner changes at some sites of MESA and in SESSA between baseline and follow-up influenced the magnitude of CAC progression, and a term for scanner pair was included in all models. 15, 22 For the analysis of CAC incidence, time between CT scans was also included in all models. Our primary analysis for the annual change in CAC score among those with detectable CAC at baseline did not control for baseline CAC score. Incorporating CAC score in the model would lead to overcorrection/overmodeling because risk factors that produce baseline CAC also contribute to CAC progression. 22, 23 In other words, baseline CAC is not a confounder but part of the causal pathway for the relation between risk factors and CAC progression. In a secondary analysis, we explored whether race/ethnic differences persisted after further adjustment for baseline CAC score. 22 To obtain relative risk for CAC incidence among those free of baseline CAC, we used Poisson regression with robust error variance-an approach that avoids convergence issues at times faced using a log-binomial model. 24 We used Poisson rather than logistic regression because incidence of CAC was >10% in both cohorts, so the odds ratio would tend to overestimate the true relative risk. To estimate the annual change in CAC score among those with baseline CAC, we used robust linear regression, downweighting the influence of participants with large progression to increase model robustness. 22 We further conducted a sensitivity analysis for CAC progression among those with detectable CAC at baseline using an additional definition as follows: annualized change in CAC score ≥10 at follow-up if baseline CAC score was >0 to <100; and annualized percentage change in CAC score ≥10% at follow-up if baseline CAC score was ≥100. 25 Analyses are performed using SAS software (version 9.4; SAS Institute, Inc, Cary, NC). Two-tailed P value of <0.05 is considered statistically significant.
RESULTS
The final MESA and SESSA cohorts for the current analysis included 1712 men in the United States (688 white, 449 black, 375 Hispanic, and 200 Chinese) and 697 Japanese men in Japan, respectively. Baseline characteristics of study participants are shown in Table 1 . Compared with Japanese men, all the US race/ethnic groups were younger, had lower levels of systolic and diastolic blood pressure and total, LDL (low-density lipoprotein), and HDL cholesterol, and smoked fewer cigarettes. Additionally, US white men had a lower prevalence of diabetes mellitus than Japanese men. Meanwhile, compared with Japanese men, US white, black, and Hispanic men had greater body mass index, US white men had a higher prevalence of statin use, and US black men had a higher prevalence of antihypertensive medication use. Time between CT scans was shorter in MESA than in SESSA. US black, Hispanic, and Chinese men had a lower CAC prevalence (CAC score, >0) compared with Japanese men, whereas among those with detectable CAC (CAC score, >0), US white, black, and Hispanic men had greater CAC score than Japanese men. Table 2 shows CAC incidence (CAC score, >0) among men without detectable CAC (CAC score=0) at baseline by race/ethnicity. We observed CAC incidence in 35.2% of white, 26.9% of black, 29.2% of Hispanic, 18.9% of Chinese US men, and 29.2% of Japanese men in Japan. After adjustment for time between CT scans, demographics, behavioral and coronary risk factors, and medication use at baseline (model 2), US white men had significantly higher CAC incidence than Japanese men (relative risk, 1.63; 95% CI, 1.12-2.38). After further adjustment for changes in behavioral and coronary risk factors and medication use between CT scans (model 3), the higher risk for CAC incidence in US white versus Japanese men persisted (relative risk, 1.68; 95% CI, 1.13-2.50). Although the point estimates suggested associations in a direction similar to that shown in US white men, the differences in the incidence of CAC among US black and Hispanic compared with Japanese men were not statistically significant in the fully adjusted model. Table 3 shows annual changes in CAC score among men with detectable CAC (CAC score, >0) at baseline by race/ethnicity. Compared with Japanese men in Japan, all the US race/ethnic groups had significantly greater annual changes in CAC score after adjustment for demographics, behavioral and coronary risk factors, and medication use at baseline (model 2 In the secondary analysis, for comparison between US black, Hispanic, and Chinese and Japanese men, the differences in annual changes in CAC score were attenuated and no longer significant after adjusting for baseline CAC score in addition to the fully adjusted model (model 3; Table I in the Data Supplement). The results from sensitivity analysis for CAC progression among men with detectable CAC (CAC score, >0) at baseline across race/ethnic groups using an additional definition are shown in Table II in the Data Supplement. Particularly, the US white men had significantly higher CAC progression than Japanese men in Japan, and the point estimates of their relative risks indicated associations in the same directions between the US men from each group even though the differences were not all statistically significant.
DISCUSSION
In this community-based longitudinal comparison between white, black, Hispanic, and Chinese men in the United States and Japanese men in Japan aged 45 to 74 years, we found a higher incidence rate of CAC among US white men and greater increases in existing CAC among all the US race/ethnic groups compared with Japanese men, even after adjusting for demographics, behavioral and traditional coronary risk factors, and medication use, such as statins at baseline, as well as their changes between CT scans. We previously reported that US white men had a higher CAC prevalence than Japanese men in Japan even after adjustment for known coronary risk factors. 14, 15 The present results are generally consistent with and extend the cross-sectional CAC incidence was defined as detectable CAC (CAC score >0) at the follow-up examination in men free of detectable CAC (CAC score=0) at baseline examination. Model 1, adjusted for age and education at baseline and CT scanner pair; model 2, adjusted for model 1+cigarette smoking status, pack-years of smoking, BMI, systolic blood pressure, antihypertensive medication use, total cholesterol, HDL cholesterol, statin use, and diabetes mellitus at baseline; model 3, adjusted for model 2+changes in cigarette smoking status, pack-years of smoking, BMI, systolic blood pressure, antihypertensive medication use, total cholesterol, HDL cholesterol, statin use, and diabetes mellitus between CT scans. Time between CT scans was further included in all models for the analysis of CAC incidence. BMI indicates body mass index; CAC, coronary artery calcium; CT, computed tomography; HDL, high-density lipoprotein; MESA, Multi-Ethnic Study of Atherosclerosis; and SESSA, Shia Epidemiological Study of Subclinical Atherosclerosis. *P<0.01, †P<0.05. Annual change in CAC was calculated as CAC score in follow-up minus CAC score at baseline divided by time between CT scans in years. P value for testing whether the difference in CAC score between each US race/ethnic group and Japanese group is significantly different from zero: *P<0.001, †P<0.01. Statistical models are shown in Table 2 . CAC indicates coronary artery calcium; CT, computed tomography; MESA, Multi-Ethnic Study of Atherosclerosis; and SESSA, Shia Epidemiological Study of Subclinical Atherosclerosis.
observations by means of a longitudinal comparison between US multiethnic (white, black, Hispanic, and Chinese) and Japanese groups.
Japanese men in Japan have been reported to have a lower CHD burden than US men. 2 Recently, however, the distributions of coronary risk factors have reached similar levels in Japan and the United States. 2 Indeed, we found that Japanese men in Japan had higher levels of blood pressure and total and LDL cholesterol and were also 1.5 to 3× more likely to smoke cigarettes than the US men. Evidence for recent trends of CHD in Japan is varied. Some prospective studies showed an increased trend in CHD incidence, particularly among men with elevated levels of serum total cholesterol, body mass index, and diabetes mellitus. 4, 5 Conversely, the Hisamaya Study-one of the best-known cohort studies in Japan-found no clear trend in the incidence of acute myocardial infarction. 26 Recently, some population-based studies in the United States have observed a decreasing trend in the incidence of CHD 6,7 coincident with improvements in total cholesterol and blood pressure levels. 3, 7 Given the possible opposite trends in risk factor levels and clinical CHD between Japan and the United States, we hypothesized that the overall burden of coronary atherosclerosis may be becoming more similar between the 2 countries as well, especially among men. However, our findings on subclinical atherosclerosis revealed that Japanese men in Japan still have less CAC incidence or increase in existing CAC than US men.
The observed difference in CAC progression between the United States and Japan may result from multiple factors. One possible factor may be a difference in duration of exposure to coronary risk factors between the US and Japanese men. Individuals with longer term exposure to coronary risk factors may have higher accumulation of calcified coronary plaque and noncalcified plaque before baseline, and it is assumed that such individuals also continue to have more rapid CAC progression thereafter because of a plaque composition shifted from noncalcified to calcified plaque. In fact, even if current total cholesterol levels between the 2 populations are comparable, the cumulative association of total cholesterol with atherosclerosis is smaller among Japanese men than among US men.
1,2 This hypothesis is supported by our interesting finding that the difference between the 2 countries was attenuated by further adjustment for baseline CAC score, which is considered related to the long-term cumulative exposure to risk factors. 22, 27 Previous studies comparing between Japanese in the United States and in Japan have also shown that Japanese in the United States had greater levels of coronary atherosclerosis burden compared with Japanese in Japan. 28, 29 This indicates that that low coronary atherosclerosis burden in Japanese in Japan is likely to be primarily because of environmental factors but not to genetic factors.
It is possible that the differences in CAC do not purely reflect differences in atherosclerosis. 30 Statins have been suggested to stabilize plaque by decreasing lipid-rich and necrotic plaque components and increasing plaque calcification. 31 In the present study, statin use was more prevalent among US white men, although US white men still had greater CAC progression than Japanese men after accounting for statin use. Bone or mineral metabolism 32, 33 or genetic factors 34, 35 are also reported to explain some of the variation in vascular calcification. Moreover, there may be potential race/ethnic differences in the distribution of calcified and noncalcified atherosclerotic plaques. CAC is a quantitative marker of the extent of coronary atherosclerotic plaque-an observation derived from pathological studies performed mostly in US white men that found strong correlations between histological plaque and calcium area. 10, 11 Unfortunately, in these pathological studies, interethnic variation in the calcium-atherosclerotic relationship has not been well described. However, a recent autopsy study found calcified plaque was consistently greater in whites than in blacks in all decades. 36 Further studies are warranted to elucidate the difference in histological distributions of calcified and noncalcified atherosclerotic plaques between the United States and Japan.
The present study is the first prospective comparative evaluation of subclinical atherosclerosis, measured as CAC progression, across population-based multiethnic (white, black, Hispanic, and Chinese) US and Japanese men with valid comparability for CAC scores. 21 Limitations of the present study warrant consideration. First, the nonstandardized measurement in both cohorts might have introduced some bias to the comparison. For example, the values of blood pressure were calculated by average of the second and third measurements in MESA, whereas those were derived from the average of the first 2 measurements in SESSA. The higher blood pressure observed in Japanese men may be partly because of methodological differences. We made several attempts to overcome this limitation, including comparability evaluation for CAC score 21 as mentioned above, use of the laboratories standardized by the US Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network for lipid measurements, and converting lipid values obtained by plasma to serum equivalents. However, other potential biases may have been in effect. Second, the different baseline period (2000-2002 and 2006-2008 , respectively) and follow-up duration (median, 3.4 and 5.2 years, respectively) in MESA and SESSA may have affected our results. We considered the differences in follow-up duration in the analysis, although their effect would not be completely controlled. As noted above, given the possible opposite trends in the incidence of CHD between the 2 countries, we could have confirmed greater difference in CAC progression between the 2 cohorts if we measured CAC in SESSA at the same baseline period and follow-up duration as in MESA. Third, our study may have been underpowered especially to detect the differences in the incidence of CAC among the US men compared with Japanese men; this is because, although the differences were not statistically significant, the point estimates of their relative risks indicated associations in the same directions between the US white, black, and Hispanic men. Finally, we studied only men, and the Japanese sample was obtained from a single area in Japan, both of which may limit the generalizability of our results. Furthermore, the possibility of selection bias needs to be considered when generalizing our findings as the participation rate of the each study was rather low.
In summary, we found a higher CAC incidence particularly among US white men and greater increases in existing CAC among all race/ethnic groups in the United States, than among Japanese men in Japan. These differences between the 2 countries were not explained by the discrepancy in the distributions of traditional coronary risk factors. These results suggest a higher coronary atherosclerosis burden and consequent risk for CHD among the US men as compared with Japanese men in Japan. In addition, we observed the difference in CAC progression among the US and Japanese men, although traditional risk factors related to CAC were largely similar across race/ethnic groups. 17, 22, 30, 37 Furthermore, explanations responsible for these differences should be sought, which may inform clinical interpretation and our understanding of the pathophysiology of coronary atherosclerosis.
